Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,067,097 papers from all fields of science
Search
Sign In
Create Free Account
GSK1265744
Known as:
GSK744
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Pyridones
Narrower (1)
cabotegravir
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial.
M. Markowitz
,
I. Frank
,
+17 authors
W. Spreen
The Lancet HIV
2017
Corpus ID: 206200928
Highly Cited
2015
Highly Cited
2015
Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised…
D. Margolis
,
C. Brinson
,
+13 authors
W. Spreen
Lancet. Infectious Diseases (Print)
2015
Corpus ID: 12772056
Highly Cited
2014
Highly Cited
2014
Antiviral Characteristics of GSK1265744, an HIV Integrase Inhibitor Dosed Orally or by Long-Acting Injection
T. Yoshinaga
,
Masanori Kobayashi
,
+11 authors
T. Fujiwara
Antimicrobial Agents and Chemotherapy
2014
Corpus ID: 25385128
ABSTRACT GSK1265744 is a new HIV integrase strand transfer inhibitor (INSTI) engineered to deliver efficient antiviral activity…
Expand
Highly Cited
2014
Highly Cited
2014
GSK1265744 Pharmacokinetics in Plasma and Tissue After Single-Dose Long-Acting Injectable Administration in Healthy Subjects
W. Spreen
,
S. Ford
,
+4 authors
S. Piscitelli
Journal of Acquired Immune Deficiency Syndromes
2014
Corpus ID: 9952206
Background:GSK1265744 (744) is an HIV-1 integrase inhibitor in clinical development as a long-acting (LA) injectable formulation…
Expand
Highly Cited
2014
Highly Cited
2014
Pharmacokinetics, Safety, and Tolerability With Repeat Doses of GSK1265744 and Rilpivirine (TMC278) Long-Acting Nanosuspensions in Healthy Adults
W. Spreen
,
P. Williams
,
+6 authors
S. Piscitelli
Journal of Acquired Immune Deficiency Syndromes
2014
Corpus ID: 45321258
Objective:Pharmacokinetics, safety, and tolerability of GSK1265744 (744) and rilpivirine (RPV) (TMC278) were assessed after…
Expand
Highly Cited
2013
Highly Cited
2013
Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744).
B. Johns
,
T. Kawasuji
,
+18 authors
T. Fujiwara
Journal of Medicinal Chemistry
2013
Corpus ID: 207231801
We report herein the discovery of the human immunodeficiency virus type-1 (HIV-1) integrase inhibitors dolutegravir (S/GSK1349572…
Expand
Highly Cited
2013
Highly Cited
2013
Pharmacokinetics, Safety, and Monotherapy Antiviral Activity of GSK1265744, an HIV Integrase Strand Transfer Inhibitor
W. Spreen
,
S. Min
,
+6 authors
T. Fujiwara
HIV Clinical Trials
2013
Corpus ID: 17900
Abstract Background: GSK1265744 is an HIV integrase strand transfer inhibitor selected for clinical development. Objective: This…
Expand
Review
2013
Review
2013
Long-acting injectable antiretrovirals for HIV treatment and prevention
W. Spreen
,
D. Margolis
,
J. Pottage
Current Opinion in HIV and AIDS
2013
Corpus ID: 14048041
Purpose of reviewLong-acting antiretroviral (ARV) drugs may improve adherence to therapy and extend opportunities for therapeutic…
Expand
Highly Cited
2013
Highly Cited
2013
Lack of Pharmacokinetic Interaction between Rilpivirine and Integrase Inhibitors Dolutegravir and GSK1265744
S. Ford
,
Elizabeth P Gould
,
+4 authors
S. Piscitelli
Antimicrobial Agents and Chemotherapy
2013
Corpus ID: 206705607
ABSTRACT Dolutegravir (DTG) and GSK1265744 are HIV integrase inhibitors (INIs) in clinical development. The oral formulation of…
Expand
Review
2013
Review
2013
Multipurpose prevention technologies: products in development.
D. Friend
,
Justin T. Clark
,
P. Kiser
,
Meredith R Clark
Antiviral Research
2013
Corpus ID: 19091194
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE